Shares of biotech stock Zogenix had an exciting trading day on Friday after the company reported positive epilepsy drug test results. The company’s drug ZX008 succeeded in showing improvements in reducing seizures for patients that have Dravet syndrome in a Phase 3 trial. Shares increased by 180% in midday trading on Friday after the company … Continue reading “Zogenix Shares Double on Epilepsy Treatment Results”
Biotech & Pharma
The FDA Has Approved the First Finger Prick-Free Diabetes Device
Millions of Americans may be thrilled to learn that the Food & Drug Administration has…
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
A Test that Can Detect Cocaine in Seconds Using a Fingerprint
Imagine being able to know if someone has been using cocaine recently in just seconds…
This U.S Drug maker Just Said it Will Lay off 20% of Its Workforce
U.S drug maker Alexion announced this week that it would be slashing 20% of its…
This Major Drug Maker Will Cut its Work Force by 9%
Indianapolis-based Eli Lilly announced on Thursday that the company will be cutting almost 9% of…
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
The First FDA Approved Therapy to Fight Leukemia is Here
The FDA has approved a gene therapy treatment for use in the U.S to Novartis…
Pfizer Sees a 50% Rise in Profit with the Help of These Drugs
Top U.S. drug maker Pfizer just reported its second quarter earnings report that beat the…
Vertex Pharmaceuticals Explodes After Announcing These Huge Results
Shares of Vertex Pharmaceuticals sailed higher on Wednesday and were up as much as 21%…
The FDA Has Been Urged to Approve A Cancer Therapy
One of the hardest diseases to fight is cancer, but there's a cutting-edge cancer therapy…
FDA Ask A Major Pharma Company To Remove A Pain Drug From The Market
Endo Pharmaceuticals had a not so good week this week. The FDA has asked the…
Americans May Have Been Overcharged $1 Billion For EpiPen Devices
According to a U.S. senator who made the remark on Wednesday, American taxpayers may have…
Gilead Shares Climb Higher After Impressive HIV Drug News
Gilead traders had something to celebrate on Tuesday. The company's HIV drug has met its…